Topic: sterile injectables
Abzena will invest $20 million in a cell manufacturing facility, and Catalent is spending $2.5 million on a clinical supply facility in China.
Big Pharma firms touted growth in China; Genentech sues ex-staffers and biosim company; Janssen licenses Yuhan's potential Tagrisso rival.
Hikma, which has established itself as a top sterile injectables manufacturer in the U.S., is now picking up a production plant in Vietnam.
Pfizer acknowledged that it continues to struggle with manufacturing at some Hospira plants, an issue that bodes ill for U.S. hospitals.
Aspen Pharmacare says it will invest nearly $235 million in a facility to manufacture sterile anesthetics.
CMO Grand River Aseptic Manufacturing is adding a $60 million manufacturing facility along with more than 100 jobs.
The FDA, which banned products from a South Korean sterile manufacturer last spring, has now followed up with a warning letter.
GlaxoSmithKline will keep its cephalosporin antibiotics business but reorganize it to be more efficient, cutting nearly 200 jobs in the U.K.
Pfizer, which has been working to build back capacity at its troubled Kansas sterile injectables plant, is adding 350 employees there.